Head-to-head · WeighScore
Bodi Envi vs Teleios Health
The verdict
Bodi Envi takes it — 71.8/100 to 60.2/100.
Bodi Envi grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Bodi Envi is a nationwide telehealth weight-loss provider offering physician-prescribed compounded semaglutide ($179/month) and tirzepatide ($249/month) at flat all-dose pricing with no consultation or…
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Bodi Envi | Teleios Health |
|---|---|---|
| WeighScore | 71.8/100 | 60.2/100 |
| Grade | C | C |
| Scorecard rank | #88 | #327 |
| Semaglutide | $179/mo | $99/mo (starting dose, compounded) |
| Tirzepatide | $249/mo | $139/mo (starting dose, compounded) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #88 · C
Strengths
- Transparent flat pricing: compounded semaglutide $179/month and tirzepatide $249/month, all doses
- No consultation or membership fees
- Free 2-day shipping included; FSA and HSA eligible
- 24/7 secure provider messaging with same-day visits and prescriptions
- Personalized dose titration with side-effect management (Zofran available)
Where it loses points
- Compounded semaglutide and tirzepatide are not FDA-approved finished products
- No insurance billing — cash-pay only
- States served are not explicitly listed (features vary by state)
- No LegitScript certification visible on the site
Graded #327 · C
Strengths
- Compounded semaglutide from $99/mo — among the lowest floor prices in cash-pay telehealth
- Compounded tirzepatide from a competitive $139/mo floor
- Markets physician (MD/DO) prescribing rather than an NP-only model
- Clean meta-tag and SEO implementation
Where it loses points
- Single-page app: state availability, pharmacy partner, dose pricing, lab requirements, and refund policy aren't visible and couldn't be verified
- No named medical director, physician, or corporate entity disclosed
- Year founded unknown — a newer floor-price entrant warranting extra scrutiny
- No LegitScript, NABP, or SOC 2 trust signal found
- Heavy paid-acquisition ad-tech stack — pair with diligence on the clinical layer
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.